Wolverine Asset Management LLC lifted its position in shares of BlackRock Health Sciences Trust (NYSE:BME – Free Report) by 30.7% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 61,346 shares of the company’s stock after purchasing an additional 14,411 shares during the quarter. Wolverine Asset Management LLC’s holdings in BlackRock Health Sciences Trust were worth $2,284,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors also recently bought and sold shares of the company. Legacy Wealth Managment LLC ID bought a new position in BlackRock Health Sciences Trust in the 2nd quarter worth $55,000. Farther Finance Advisors LLC purchased a new stake in BlackRock Health Sciences Trust in the second quarter valued at $75,000. SOA Wealth Advisors LLC. raised its holdings in BlackRock Health Sciences Trust by 20.3% in the 3rd quarter. SOA Wealth Advisors LLC. now owns 2,780 shares of the company’s stock worth $103,000 after purchasing an additional 469 shares during the period. Geneos Wealth Management Inc. increased its position in BlackRock Health Sciences Trust by 200.0% during the second quarter. Geneos Wealth Management Inc. now owns 4,899 shares of the company’s stock worth $179,000 after purchasing an additional 3,266 shares during the last quarter. Finally, Sage Investment Counsel LLC purchased a new stake in BlackRock Health Sciences Trust during the third quarter worth about $201,000.
BlackRock Health Sciences Trust Stock Performance
Shares of BlackRock Health Sciences Trust stock opened at $41.79 on Friday. BlackRock Health Sciences Trust has a 12-month low of $34.18 and a 12-month high of $42.46. The company has a fifty day simple moving average of $40.93 and a 200-day simple moving average of $38.27.
BlackRock Health Sciences Trust Dividend Announcement
About BlackRock Health Sciences Trust
BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.
Further Reading
- Five stocks we like better than BlackRock Health Sciences Trust
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Want to see what other hedge funds are holding BME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Trust (NYSE:BME – Free Report).
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.
